15.2: Mitral Valve Prolapse II: Assessment and Management

Introduction

A range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:

1. Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
2. Chest Pain: Patients may experience atypical chest pain that is not necessarily related to coronary artery disease or exertion. The intensity of pain can vary and is frequently not associated with physical activity.
3. Murmurs: A critical clinical sign of MVP is a mid-to-late systolic click, followed by a late systolic murmur, best heard at the apex of the heart. This sound is due to the sudden tensing of the valve leaflets and chordae tendineae.
4. Dyspnea: Difficulty breathing or shortness of breath, particularly during physical activity, can occur in MVP, especially if the condition is accompanied by significant mitral regurgitation.
5. Fatigue: MVP can cause a general feeling of tiredness and low energy, though it is non-specific.
6. Dizziness or Lightheadedness: These symptoms can arise from arrhythmias associated with MVP or inadequate cardiac output if the condition is severe.
7. Syncope (Fainting): It is less common, but syncope can occur, particularly in significant arrhythmias.
8. Anxiety: Some patients with MVP may experience heightened levels of anxiety, although this is not a direct symptom of MVP itself.

Assessment and Diagnosis

• Patient History: The first step in assessing MVP is taking a thorough history. This helps determine whether the patient is asymptomatic or experiencing MVP-related symptoms.
• Physical Examination: This exam focuses on cardiac auscultation to detect specific sounds, such as mid-systolic clicks and late systolic murmurs, indicative of MVP. Symptoms such as palpitations, chest pain, dyspnea, fatigue, dizziness, and syncope are also evaluated.
• Family History: Considering the patient's family history is essential due to the potential genetic links of MVP.

Diagnostic Tools

• Transthoracic Echocardiography is the primary tool for diagnosing MVP. It assesses mitral leaflet thickening, prolapse extent, and the severity of mitral regurgitation.
• Electrocardiogram (ECG): Used to identify any associated arrhythmias.
• Chest X-Ray: Helps assess the heart's size, particularly relevant in suspected congestive heart failure cases.
• Cardiac MRI: Offers detailed anatomical imaging and is beneficial for further evaluation of the mitral valve in specific scenarios.

Management Strategies

• Medical Management: Includes beta-blockers for symptom relief. In patients with risks like atrial fibrillation, aspirin or anticoagulants may be prescribed.
• Regular Monitoring: Echocardiography is crucial for assessing the valve's function and the heart's response to MVP.
• Surgical Intervention: Mitral valve replacement or repair is considered in cases of severe mitral regurgitation or left ventricular dysfunction.

Lifestyle Modifications and Patient Education

• Lifestyle Changes: Regular exercise, avoiding stimulants like caffeine and alcohol, and quitting tobacco and electronic nicotine delivery systems.
• Patient Education is vital for understanding the condition, monitoring symptoms, and knowing the importance of endocarditis prophylaxis, especially before dental procedures.